Skip to content
  • Login
  • Signup
Drug Shortages

Midazolam Injection

Posted on by Editor

Presentation

10 ML Vial – Pack of 10 (NDC 17478-0524-10)

Availability and Estimated Shortage Duration

Available

Related Information

 

Shortage Reason (per FDASIA)

 

US FDA Link: https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Midazolam%20Injection&st=c&tab=tabs-1

This entry was posted in Drug Shortages. Bookmark the permalink.
Metronidazole Injection
Misoprostol Tablets
Latest Posts
  • 22
    Jul
    Potency Assays: a hands on review and general instructions Comments Off on Potency Assays: a hands on review and general instructions
  • 07
    Jul
    FULE methodology for autonomous medical devices Comments Off on FULE methodology for autonomous medical devices
  • 30
    Jun
    Immunological Responses to AAV Gene Therapy in NC Comments Off on Immunological Responses to AAV Gene Therapy in NC
  • 30
    Jun
    Ethical Limits of Gene Therapy: a new barrier Comments Off on Ethical Limits of Gene Therapy: a new barrier
  • 30
    Jun
    Global Outreach Opportunities in Advancing science Comments Off on Global Outreach Opportunities in Advancing science
  • 30
    Jun
    Multiple First Approvals for Gene, RNA Therapies Comments Off on Multiple First Approvals for Gene, RNA Therapies
  • 28
    Jun
    FDA’s Medical Product User Fees Reauthorized Comments Off on FDA’s Medical Product User Fees Reauthorized
  • 28
    Jun
    Regenerative Medicine Advancements and trends Comments Off on Regenerative Medicine Advancements and trends
About us
Templar Pharmaceuticals offers Regulatory and Quality Compliance services to USFDA Registered companies. Our client base ranges from start-ups through to medium sized companies. Templar Pharmaceuticals has network of professionals who able to support companies with dedicated technical services for US regulated products.
Customer Sevice

Templar Pharmaceuticals, LLC

7520 West Waters Ave. Unit # 5
Tampa, Florida – 33615

  617-653-0647

Signup for Newsletter

    Copyright 2023 © Templar Pharmaceuticals, LLC
    • Send US A MESSAGE
    • Login
    • Signup